PreDiagnose ApS: Financial statements 2019
CVR: 38562770
Source: annual report 2019, Danish Business Authority
01/01/2019 – 31/12/2019
PreDiagnose ApS (CVR 38562770) has filed annual accounts for 2019. In 2019, the company reported a gross profit of DKK 109,019 and a net result of DKK 82,493 compared with DKK 0 the year before. Equity in the 2019 report amounted to DKK 83,163. The solvency ratio was 20.6%. The company had 1 employee in the financial year.
- Gross Profit
- DKK 109,019
- Profit/Loss
- DKK 82,493
- Equity
- DKK 83,163
- Total Assets
- DKK 404,101
- Employees
- 1
Official annual report
Screen every Danish company
Combine filters on financials, industry, geography, property and risk, and instantly see which companies match.
Try company screeningEvents in 2019
As of September 11, 2019, Jafar Safaa Noori is registered as adm. dir. of PreDiagnose ApS.
As of September 11, 2019, Fatima Al-Zahraa Al Atraktchi has stepped down as adm. dir. of PreDiagnose ApS.
PreDiagnose ApS has published its annual report for 2018. Gross profit came to DKK 0, and the net result was DKK 0.
About PreDiagnose ApS
PreDiagnose ApS is a Danish company of the type Anpartsselskab based in Karlslunde, founded in 2017. The company is registered under the industry Forskning og eksperimentel udvikling inden for naturvidenskab og teknik. The company was previously named PreDiagnose IVS. The management consists of Fatima Al-Zahraa Al Atraktchi. The company is owned by FZA ApS. The company has 1 employee (2023). In 2025, the company reported a gross profit of DKK 129,206 and a net result of DKK 2,564 compared with DKK 60,353 the year before. Equity in the 2025 report amounted to DKK 1,203,779.